How have TNLX shares performed in 2024?

Trans-Lux's stock was trading at $0.80 at the beginning of 2024. Since then, TNLX shares have increased by 0.0% and is now trading at $0.80. View the best growth stocks for 2024 here .

Are investors shorting Trans-Lux?

Trans-Lux saw a increase in short interest in March. As of March 31st, there was short interest totaling 200 shares, an increase of 100.0% from the March 15th total of 100 shares. Based on an average daily trading volume, of 700 shares, the short-interest ratio is presently 0.3 days. View Trans-Lux's Short Interest .

When is Trans-Lux's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our TNLX earnings forecast .

What other stocks do shareholders of Trans-Lux own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trans-Lux investors own include Co-Diagnostics (CODX) , FuelCell Energy (FCEL) , iBio (IBIO) , Ocugen (OCGN) , SANUWAVE Health (SNWV) , Sierra Oncology (SRRA) , Tonix Pharmaceuticals (TNXP) and Ascent Solar Technologies (ASTI) .

How do I buy shares of Trans-Lux?

Shares of TNLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:TNLX

Trans-Lux (TNLX) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free TNLX Stock Alerts

$0.80

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.80
▼
$0.80
50-Day Range: $0.56
▼
$0.90
52-Week Range: $0.30
▼
$0.95

Volume: 100 shs
Average Volume: 586 shs
Market Capitalization: $10.80 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials SEC Filings Short Interest

Get Trans-Lux alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Trans-Lux Stock (OTCMKTS:TNLX)

Trans-Lux Corporation designs and manufactures digital display solutions and fixed digit scoreboards. It operates in two segments, Digital Product Sales; and Digital Product Lease and Maintenance. The Digital Product Sales segment sells indoor and outdoor digital product signage products. The Digital Product Lease and Maintenance segment is involved in the lease and maintenance of indoor and outdoor digital product signage. The company offers LED display systems for use by sports arenas and stadiums; financial institutions, including brokerage firms, banks, energy companies, insurance companies, and mutual fund companies; educational institutions; outdoor advertising companies; corporate and government communication centers; retail outlets; casinos, racetracks, and other gaming establishments; airports, train stations, bus terminals, and other transportation facilities; movie theatres; and health maintenance organizations, as well as in various other applications. It also provides TLVision, which consists of full-color video products for use in posting alphanumeric data and displaying of full HD video; and turnkey installation and support services. The company markets its products through direct sales representatives, and a network of independent dealers and distributors in the United States and Canada; and internal sales people and independent distributors in the rest of North America, Europe, the Middle East, South America, Africa, the Far East, and Australia. Trans-Lux Corporation was incorporated in 1920 and is headquartered in New York, New York.

TNLX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TNLX Stock News Headlines

October 29, 2023 | nypost.com

Virginia college swimmers reveal fight to keep trans athlete from joining women’s team after competing as male

August 21, 2023 | foxnews.com

Tennis official in Wyoming resigns in protest of trans athlete's participation in women's category

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

July 31, 2023 | dailymail.co.uk

Transgender Issues - News and Updates on Gender Ideology

June 13, 2023 | ca.style.yahoo.com

N.B. premier faces backlash after trans policy change — why experts say it's ‘embarrassing’

May 16, 2023 | seekingalpha.com

TNLX Trans-Lux Corporation

April 5, 2023 | yahoo.com

Lux Capital ditches its opportunity fund in latest fundraise

April 1, 2023 | finance.yahoo.com

Trans-Lux Corporation (TNLX)

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

February 16, 2023 | nypost.com

‘Trans Lives Matter’ activists occupy rotunda of Oklahoma Capitol

August 13, 2022 | reuters.com

Trans Lux Corp

July 19, 2022 | benzinga.com

Trans-Lux (OTC:TNLX), Earnings Estimates, EPS, and Revenue

See More Headlines

Receive TNLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trans-Lux and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/13/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Computer and Technology
Industry: Miscellaneous manufacturing industries
Sub-Industry: N/A
Current Symbol: OTCMKTS:TNLX
CUSIP: N/A
CIK: 99106
Web: www.trans-lux.com
Phone: (800) 243-5544
Fax: 203-866-9496
Employees: 53
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.20)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,070,000.00
Net Margins: -26.15%
Pretax Margin: -25.95%
Return on Equity: N/A
Return on Assets: -44.62%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.23
Quick Ratio: 0.10

Sales & Book Value

Annual Sales: $15.55 million
Price / Sales: 0.69
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($1.05) per share
Price / Book: -0.76

Miscellaneous

Outstanding Shares: 13,500,000
Free Float: 5,574,000
Market Cap: $10.80 million
Optionable: Not Optionable
Beta: -0.59

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Nicholas J. Fazio (Age 44)
CEO & Director
Mr. Yantao Yu (Age 48)
Executive VP, COO & Director
Mr. Todd Dupee (Age 52)
Senior VP, Chief Accounting Officer & Assistant Corporate Secretary
Comp: $157.59k
Mr. John C. Hammock (Age 61)
Senior VP and Chief Sales & Marketing Officer
Comp: $208.39k
Mr. Thomas E. Durkin III (Age 70)
Executive VP, General Counsel & Corporate Secretary
Ms. Jane Bauer
Vice President of Human Resources
Mr. Alexandro Gomez (Age 54)
Senior VP & Chief Relationship Officer
Comp: $236.2k
Mr. David Pavlik
President of Trans-Lux Energy Corporation

Key Competitors

View All Competitors

TNLX Stock Analysis - Frequently Asked Questions

How have TNLX shares performed in 2024?: Trans-Lux's stock was trading at $0.80 at the beginning of 2024. Since then, TNLX shares have increased by 0.0% and is now trading at $0.80.
View the best growth stocks for 2024 here.
Are investors shorting Trans-Lux?: Trans-Lux saw a increase in short interest in March. As of March 31st, there was short interest totaling 200 shares, an increase of 100.0% from the March 15th total of 100 shares. Based on an average daily trading volume, of 700 shares, the short-interest ratio is presently 0.3 days.
View Trans-Lux's Short Interest.
When is Trans-Lux's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our TNLX earnings forecast.

What other stocks do shareholders of Trans-Lux own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Trans-Lux investors own include Co-Diagnostics (CODX), FuelCell Energy (FCEL), iBio (IBIO), Ocugen (OCGN), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP) and Ascent Solar Technologies (ASTI).
How do I buy shares of Trans-Lux?: Shares of TNLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TNLX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Trans-Lux (TNLX) Stock Price, News & Analysis

About Trans-Lux Stock (OTCMKTS:TNLX)

TNLX Stock Price History

TNLX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

TNLX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info